Starling GC - Search Results

1

Fused pyrimidine based inhibitors of phosphodiesterase 7 (PDE7): synthesis and initial structure-activity relationships.

Kempson J, Pitts WJ, Barbosa J, Guo J, Omotoso O, Watson A, Stebbins K, Starling GC, Dodd JH, Barrish JC, Felix R, Fischer K. Kempson J, et al. Among authors: starling gc. Bioorg Med Chem Lett. 2005 Apr 1;15(7):1829-33. doi: 10.1016/j.bmcl.2005.02.025. Bioorg Med Chem Lett. 2005. PMID: 15780616

2

Identification of purine inhibitors of phosphodiesterase 7 (PDE7).

Pitts WJ, Vaccaro W, Huynh T, Leftheris K, Roberge JY, Barbosa J, Guo J, Brown B, Watson A, Donaldson K, Starling GC, Kiener PA, Poss MA, Dodd JH, Barrish JC. Pitts WJ, et al. Among authors: starling gc. Bioorg Med Chem Lett. 2004 Jun 7;14(11):2955-8. doi: 10.1016/j.bmcl.2004.03.021. Bioorg Med Chem Lett. 2004. PMID: 15125967

3

Retinoic acid and vitamin E modulate expression and release of CD178 in carcinoma cells: consequences for induction of apoptosis in CD95-sensitive cells.

Salih HR, Starling GC, Knauff M, Llewellyn MB, Davis PM, Pitts WJ, Aruffo A, Kiener PA. Salih HR, et al. Among authors: starling gc. Exp Cell Res. 2001 Nov 1;270(2):248-58. doi: 10.1006/excr.2001.5346. Exp Cell Res. 2001. PMID: 11640888

4

The membrane-proximal scavenger receptor cysteine-rich domain of CD6 contains the activated leukocyte cell adhesion molecule binding site.

Whitney GS, Starling GC, Bowen MA, Modrell B, Siadak AW, Aruffo A. Whitney GS, et al. Among authors: starling gc. J Biol Chem. 1995 Aug 4;270(31):18187-90. doi: 10.1074/jbc.270.31.18187. J Biol Chem. 1995. PMID: 7543097 Free article.

5

Identification of amino acid residues important for ligand binding to Fas.

Starling GC, Bajorath J, Emswiler J, Ledbetter JA, Aruffo A, Kiener PA. Starling GC, et al. J Exp Med. 1997 Apr 21;185(8):1487-92. doi: 10.1084/jem.185.8.1487. J Exp Med. 1997. PMID: 9126929 Free PMC article.

6

Constitutive expression of functional 4-1BB (CD137) ligand on carcinoma cells.

Salih HR, Kosowski SG, Haluska VF, Starling GC, Loo DT, Lee F, Aruffo AA, Trail PA, Kiener PA. Salih HR, et al. Among authors: starling gc. J Immunol. 2000 Sep 1;165(5):2903-10. doi: 10.4049/jimmunol.165.5.2903. J Immunol. 2000. PMID: 10946324

7

Analysis of the ligand binding site in Fas (CD95) by site-directed mutagenesis and comparison with TNFR and CD40.

Starling GC, Kiener PA, Aruffo A, Bajorath J. Starling GC, et al. Biochemistry. 1998 Mar 17;37(11):3723-6. doi: 10.1021/bi972959d. Biochemistry. 1998. PMID: 9521690

8

Human monocytic cells contain high levels of intracellular Fas ligand: rapid release following cellular activation.

Kiener PA, Davis PM, Rankin BM, Klebanoff SJ, Ledbetter JA, Starling GC, Liles WC. Kiener PA, et al. Among authors: starling gc. J Immunol. 1997 Aug 15;159(4):1594-8. J Immunol. 1997. PMID: 9257817

9

Differentiation of promyelocytic leukaemia: alterations in Fas (CD95/Apo-1) and Fas ligand (CD178) expression.

Salih HR, Starling GC, Brandl SF, Pelka-Fleischer R, Haferlach T, Hiddemann W, Kiener PA, Nuessler V. Salih HR, et al. Among authors: starling gc. Br J Haematol. 2002 Apr;117(1):76-85. doi: 10.1046/j.1365-2141.2002.03382.x. Br J Haematol. 2002. PMID: 11918536 Free article.

10

Soluble CD137 (4-1BB) ligand is released following leukocyte activation and is found in sera of patients with hematological malignancies.

Salih HR, Schmetzer HM, Burke C, Starling GC, Dunn R, Pelka-Fleischer R, Nuessler V, Kiener PA. Salih HR, et al. Among authors: starling gc. J Immunol. 2001 Oct 1;167(7):4059-66. doi: 10.4049/jimmunol.167.7.4059. J Immunol. 2001. PMID: 11564827

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

53 results

Search Page

Filters